DECAPHAR
Group
has 4 direct subsidiaries (2025 accounts)Parent4 holdings, 1 country
2025 accounts
Belgium 4 Equity Result
- BE Decaphar €316,271 result €82,626
- BE €190,377 result €81,596
- BE €183,267 result €17,048
- BE €166,349 result €38,414
Source: list of holdings in the 2025 accounts of . Every holding stands with its own latest accounts.
At the same address
Diependale 8, 9700 Oudenaarde · 4 other companies| Conrad Pharma
registered office since 23-07-2013 · founded in 2013 |
2.5 FTE (2025) 0536.875.697 |
| GEVA PHARMA
registered office since 09-08-1985 · founded in 1985 |
1.8 FTE (2025) 0427.597.576 |
| VERZELE PHARMA
registered office since 28-03-2008 · founded in 2008 |
2 FTE (2025) 0896.764.703 |
| VERZELE PHARMA ZWALM
registered office since 06-07-2001 · founded in 2001 |
total assets €431,191 (2025) 0475.231.407 |
Earlier ties
via (at DECAPHAR until 2020) and (at DECAPHAR until 2020) · Director · deed of 27-04-2012 Dissolved |
Acquisitions and mergers
4 transactionsReceived in a demerger part of:DECAMED
Received a branch of activity from:Dominique Declerck
Received a branch of activity from:Karine Allegaert
Split off to:ERUDITE PHARMA
Connections & network
3 connected companiesThis company
Company
Director
Shareholding
+N: links not shown yet
Bankruptcy, dissolution or liquidation
Click a node to look further, drag to arrange, zoom with the mouse wheel.
Linked via shared directors
via · Director (not named in the articles) · deed of 24-01-2024
Founded in 1985 · 1.8 FTE (2025)
via · Director (not named in the articles) · deed of 24-01-2024
Founded in 2008 · 2 FTE (2025)
via · Director (not named in the articles) · deed of 24-01-2024
Founded in 2001 · total assets €431,191 (2025)